Ep. 344 Insights into RVUs: Historical Context & Recent Changes with Dr. Kyle Richards
50 min
If you’ve felt penalized for getting faster in the OR, you’re not imagining it. On this episode of BackTable Urology, Dr. Ruchika Talwar interviews Dr. Kyle Richards, urologic oncologist at the University of Wisconsin and the American Urological Association's (AUA) representative on the RVS Update Committee (RUC), about how relative value units (RVUs) are set and who decides what a procedure is worth. Dr. Richards traces RVUs from their 1989 origins to the physician surveys behind every recommendation the RUC sends to Medicare, explains how a new technology earns a CPT code and a value, and shares why urology's single seat on the 31-member committee makes every survey response count. --- Get the BackTable apphttps://www.backtable.com/app --- This podcast was developed in collaboration with Society of Urologic Oncologyhttps://suonet.org/home --- Timestamps 00:00 - Introduction02:27 - What Is an RVU?05:31 - Who Decides What a Procedure Is Worth08:04 - How the RUC Works With CMS10:10 - New Technology and New CPT Codes13:32 - Inside the RUC Survey18:26 - Who Sits on the RUC and How It Votes22:08 - Budget Neutrality and the Conversion Factor25:04 - Is Efficiency Being Penalized?29:27 - New Codes for Retroperitoneal Cytoreduction33:09 - Prostate Biopsy Codes and Practice Expense36:47 - How Robotic Prostatectomy Has Been Valued45:46 - How Urologists Can Get Involved ---More about this episodeDr. Kyle Richards explains how shorter intra-service times, budget neutrality, and Medicare's recent efficiency adjustment push RVUs down as procedures get faster, why practice expense makes up nearly half of a procedure's total RVUs, and why publications that showcase the fastest surgeon can make an appeal harder. He highlights recent wins for urology, including new codes for retroperitoneal cytoreduction after chemotherapy and for fusion, MRI-guided, and transperineal prostate biopsy, and tells the full story of how robotic prostatectomy has been valued, cut, appealed, and b...